Antifungal therapy for keratomycoses

Expert Opinion on Pharmacotherapy

Volumn 5, Issue 4, 2004, Pages 865-874

  Ganegoda, Nihal ^a,b   Rao, Srinivas K ^a  

^a MEDICAL RESEARCH FOUNDATION   (India)

^b Eye Hospital   (Sri Lanka)

Author keywords

Antibiotic sensitivity; Azoles; Chlorhexidine; Corticosteroids; Culture; Ergosterol; Filamentous fungi; Intracameral injection; Keratomycoses; Polyene; Polymerase chain reaction; Smear examination; Yeast

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CHLORHEXIDINE; CLOTRIMAZOLE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; ECONAZOLE; ENZYME INHIBITOR; ERGOSTEROL; FLUCONAZOLE; FLUCYTOSINE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NATAMYCIN; NYSTATIN; POLYENE ANTIBIOTIC AGENT; POSACONAZOLE; PREDNISOLONE; PYRIMIDINE DERIVATIVE; RIFAMPICIN; SQUALENE MONOOXYGENASE; TERBINAFINE; TRIAZOLE DERIVATIVE; UNINDEXED DRUG; VORICONAZOLE;

ANEMIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; CARDIOTOXICITY; CHILL; CORNEA PERFORATION; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENTIATION; DRUG TISSUE LEVEL; EARLY DIAGNOSIS; EYE DISEASE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; KERATITIS; KERATOMYCOSIS; KERATOPATHY; LIVER TOXICITY; NAUSEA AND VOMITING; NEPHROTOXICITY; PUBLICATION; REVIEW; SIDE EFFECT; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; THROMBOPHLEBITIS; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; AZOLES; CORNEAL DISEASES; COST-BENEFIT ANALYSIS; EYE INFECTIONS, FUNGAL; FLUCYTOSINE; GLUCOCORTICOIDS; HUMANS; POLYENES;

EID: 1842832772     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.5.4.865     Document Type: Review

References (64)

1. WHITCHER JP, SRINIVASAN M, UPADHYAY MP: Prevention of corneal ulceration in the developing world. Int. Ophthalmol. Clin. (2002) 42(1):71-77.
2. O'DAY DM: New antifungal drugs in ophthalmology. Int. Ophthalmol. Clin. (1996) 36(2):45-51.
3. THOMAS PA: MyAotic keratitis: an underestimated mycosis. J. Med. Vet. Mycol. (1994) 32:295-297.
4. LEBER TH: Keratomycosis aspergillina als ursache von hypopyon keratitis. Graefes. Arch. Ophthalmol. (1879) 25:285-301.
5. MICHELE M: Fungal keratitis. Review. Int. Ophthalmol. Clin. (1998) 38:115-123.
6. GOPINATHAN U, GARG P, FERNANDES M, SHARMA S, ATHMANATHAN S, RAO GN: The epidemiological features and laboratory results of fungal keratitis. Cornea (2002) 21(6):555-559.
7. SRINIVASAN M, GONSALES CA, GEORGE C et al.: Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br. J. Ophthalmol. (1997) 81:965-971.
8. ROSA RH Jr, MILLER D, ALFONSO EC: The changing spectrum of fungal keratitis in south Florida. Ophthalmology (1994) 101:1005-1013.
9. HAGAN M, WRIGHT E, NEWMAN M, JOHNSON G: Causes of suppurative keratitis in Ghana. Br. J. Ophthalmol. (1995) 79:1024-1028.
10. TANURE MAG, COHEN EJ, SUDESH S, RAPUANO CJ, LAIBSON PR. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea (2000) 19(3): 307-312.
11. KARP CL, TULI SS, YOO SH et al.: Infectious keratitis after LASIK. Ophthalmology (2003) 110-503-510.
12. TAMCELIK N, OZDAMAR A, KIZILKAYA M, DEVRANOGLU K, USTUNDAG C, DEMIRKESEN C: Fungal keratitis after nonpenetrating glaucoma surgery. Cornea (2002) 21(5):532-534.
13. SRIDHAR MS, GOPINATHAN U, RAO GN: Fungal keratitis associated with vernal keratoconjunctivitis. Cornea (2003) 22(1):80-81.
14. KISLA TA, CU-UNJIENG A, SIGLER L, SUGAR J: Medical management of Beauveria bassiana keratitis. Cornea (2000) 19(3):405-406.
15. SHIN JY, KIM HM, HONG JW: Keratitis caused by Verticillium species. Cornea (2002) 21(2):240-242.
16. WU Z, YING H, YIU S, IRVINE J, SMITH R: Fungal keratitis caused by Scedosporium apiospermum. Report of two cases and review of treatment. Cornea (2002) 21(5):519-523.
17. WEICHEL ED, BOWER KS, WARD TP, HIDAYAT A: Epicorneal aspergilloma after penetrating keratoplasty. Cornea (2002) 21(8):825-827.
18. DURSUN D, FERNANDEZ V, MILLER D, ALFONSO EC: Advanced Fusarium keratitis progressing to endophthalmitis. Cornea (2003) 22(4):300-303.
19. SRIDHAR MS, SHARMA S, GOPINATHAN U, RAO GN: Anterior chamber tap. Diagnostic and therapeutic indications in the management of ocular infections. Cornea (2002) 21(7):718-722.
20. GAUDIO PA, GOPINATHAN U, SANGWAN V, HUGHES TE: Polymerase chain reaction based detection of fungi in infected corneas. Br. J. Ophthalmol. (2002) 86:755-760.
21. FERRER C, MUNOZ G, ALIO JL, COLOM F: Polymerase chain reaction diagnosis in fungal keratitis caused by Alternaria alternata. Am. J. Ophthalmol. (2002) 133:398-399.
22. AVUNDUK AM, BEUERMAN RW, VARNELL ED, KAUFMAN HE: Confocal microscopy of Aspergillus fumigatus keratitis. Br. J. Ophthalmol. (2003) 87:409-410.
23. LECK AK, THOMAS PA, HAGAN M et al.: Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br. J. Ophthalmol. (2002) 86:1211-1215.
24. LEMP MA, BLACKMAN HJ, KOFFLER BH: Therapy for bacterial and fungal infections. Int. Ophthalmol. Clin. (1980) 20(3):135-147.
25. MANZOURI B, VAFIDIS GC, WYSE RKH: Pharmacotherapy of fungal eye infections. Expert. Opin. Pharmacother. (2001) 200:1849-1857.
26. O'BRIEN TP, GREEN WR: Fungus infections of the eye and periocular tissues. In: PaAhobiology of ocular disease: a dynamic approach, Part A (2nd edn). Garner A. Klintworth GK (Eds), Marcel Dekker, New York, USA (1994):299-333.
27. BEHRENS-BAUMANN W: Topical antimycotics in ophthalmology. Ophthalmologica (1997) 211(Suppl.1):33-38.
28. BEHRENS-BAUMANN W: Mycosis of the eye and its adnexa. Dev. Ophthalmol. (1999) 32.
29. NULENS E, EGGINK C, VERWEIJ PE: Combination therapy for keratitis by the fungus Scedosporium. Cornea (2003) 22(1):92.
30. MARTIN MJ, RAHMAN MR, JOHNSON GJ, SRINIVASAN M, CLAYTON YM: Mycotic keratitis: Susceptibility to antiseptic agents. Int. Ophthalmol. (1996) 19:299-302.
31. PERRY HD, DOSHI SJ, DONNENFELD ED, BAI GS: Topical cyclosporine A in the management of therapeutic keratoplasty far mycotic keratitis. Cornea (2002) 21(2):161-163.
32. BRAITBERG J, ELBERG S, MADDOCK J, KOBAYASHI G, SCHLESINGER D, MADDOCK G: Stimulatory, permeabilizing, and toxic effects of amphotericin B on L-cells. Antimicrob. Agents. Chemother. (1984) 26:892-897.
33. BOLARD J, LEGRAND P, HEITZ F, CYBULSKA V: One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. Biochemistry (Mosc) (1991) 30:5707-5715.
34. SANDRA FS, RUSSEL LJ: Immunopotentiating effects of amphotericin B: 1. Enhanced contact sensitivity in mice. J. Immunol. (1979) 123:2878-2882.
35. MARTIN E, STUBEN A, GORZ A, WELLER U, BHAKDI S: Novel aspect of amphotericin B action: Accumulation in human monocytes potentiates killing of phagocytosed Candida albicans. Antimicrob. Agents. Chemother. (1994) 38:13-22.
36. HO PC, TOLENTINO FI, BAKER AS: Successful treatment of exogenous Aspergillus endophthalmitis: A case report. Br. J. Ophthalmol. (1984) 69:412-415.
37. KURIAKOSE T, KOTHARI M, PAUL P, JACOB P, THOMAS R: Intracameral amphotericin B injection in the management of deep keratomycosis. Cornea (2002) 21(7):653-656.
38. KAUSHIK S, RAM J, BRAR GS, JAIN AK, CHAKRABORTI A, GUPTA A: Intracameral amphotericin B. Initial experience in severe keratomycosis. Cornea (2001) 20(7):715-719.
39. MADDUX MS, BARRIERE SL: A review of complications of amphotericin B therapy: Recommendations for prevention and management. Drug. Intell. Clin. Pharm. (1980) 177-181.
40. BUTLER WT, BENNETT JE, ALLING DW, WERTLAKE PT, UTZ JP, HILL GJ: Nephrotoxicity of amphotEricin B: early and late effects in 81 patients. Am. Intern. Med. (1964) 61:175-187.
41. GOLDBLUM D, FRUEH BE, ZIMMERLI S, BOHNKE M: Treatment of postkeratitis Fusarium endophthalmitis with amphotericin B lipid complex. Cornea (2000) 19(6):853-856.
42. MEDOFF G: Antifungal action of rifampin. Rev. Infect. Dis. (1983) 5(Suppl. 3):S614-S619.
43. EDWARDS J, MORRISON J, HENDERSON D, MONTGOMERIE J. Combined effective amphotericin B and rifampin on Candida species. Antimicrob. Agents. Chemother. (1980) 17:484-487.
44. BRAITBERG J, KOBAYASHI D, MEDOFF J, KOBAYASHI G. Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics. J. Infect. Dis. (1982) 146:138-146.
45. MASON J, PARKER J: Subconjunctival miconazole and interior segment blastomycosis. Am. J. Ophthalmol. (1993) 116:506-507.
46. O'DAY DM, ROBINSON R, HEAD WS: Efficacy of antifungal agents in the cornea Invest. Ophthalmol. Vis. Sci. (1983) 24:1098-1102.
47. O'DAY DM. Selection of appropriate antifungal therapy. Cornea (1987) 6:235-245.
48. BOSSCHE VH, MARICHAL P: Mode of action of anti-Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors. Am. J. Obstet. Gynecol. (1991) 165:1193-1199.
49. YAMAGUCHI H, ABE S, TOKUDA Y: Immunomodulating activity of antifungal drugs. Ann. NY Acad. Sci. (1993) 685:447-457.
50. PRAJNA NV, JOHN RK, NIRMALAN PK, LALITHA P, SRINIVASAN M: A randomized clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br. J. Ophthalmol. (2003) 87:1235-1237.
51. RAO SK, MADHAVAN HN, RAO G, PADMANABHAN P: Fluconazole in filamentous fungal keratitis. Cornea (1997) 16:700.
52. SHAH KB, WU TG, WILHELMUS KR, JONES DB: Activity of voriconazole against corneal isolates of Scedosporium apiospermum. Cornea (2003) 22(1):33-36.
53. SPONSEL WE, GRAYBILL JR, NEVAREZ HL, DANG D: Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis. Br. J. Ophthalmol. (2002) 86(7):829-30
54. SCHREIBER W, OLBRISCH A, VORWERK CK, KONIG W, BEHRENS-BAUMANN W: Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. Invest. Ophthalmol. Vis. Sci. (2003) 44:2634-2643.
55. BELL NP, KARP CL, ALFONSO EC, SCHIFFMAN J, MILLER D: Effects of methylprednisolone and cyclosporine A on fungal growth in vitro. Cornea (1999) 18(3):306-313.
56. INOUE T, INOUE Y, ASARI S et al.: Utility of Etest in choosing appropriate agents to treat fungal keratitis. Cornea (2001) 20(6):607-609.
57. YOO SH, DURSUN D, DUBOVY S et al.: Iontophoresis for the treatment of Paecilomyces keratitis. Cornea (2002) 21(1):131-132.
58. GARG P, GOPINATHAN U, NUTHETI R, RAO GN: Clinical experience with n-butyl cyanoacrylate tissue adhesive in fungal keratitis. Cornea (2003) 22(5):405-408.
59. KIM JS, KIM JC, HAHN TW, PARK WC: Amniotic membrane transplantation in infectious corneal ulcer. Cornea (2001) 20(7):720-726.
60. MA DHK, WANG SF, SU WY, TSAI RJF: Amniotic membrane graft for the management of scleral melting and corneal perforation in recalcitrant infectious scleral and corneo-scleral ulcers. Cornea (2002) 21(3):275-283.
61. XIE L, SHI W, LIU Z, LI S: Lamellar keratoplasty for the treatment of fungal keratitis. Cornea (2002) 21(1):33-37.
62. KILLINGSWORTH DW, STERN GA, DRIEBE WT, KNAPP A, DRAGON DM: Results of therapeutic penetrating keratoplasty. Ophthalmology (1993) 100:534-541.
63. WONG TY, NG TP, FONG KS, TAN DT: Risk factors and clinical outcomes between fungal and bacterial keratitis: A comparative study. CLAO J. (1997) 23:275-281.
64. VEMUGANTI GK, GARG P, GOPINATHAN U, NADUVILATH et al.: Evaluation of agent and host factors in progression of mycotic keratitis. A. Histologic and microbiologic study of 167 corneal buttons. Ophthalmology (2002) 109:1538-1546.